Table 2.
Schedule of measurements.
| Variable | Instrument | Time Point |
|---|---|---|
| Self-report | ||
| Premenstrual symptoms | DRSP | Two cycle baseline, each treatment cycle, natural follow up |
| Psychiatric status (mood disorders only) | Structured Clinical Interview (for DSM-5)-Research Version (SCID-1/RV) * | Screening |
| Depression, anxiety, stress | Depression and Anxiety Stress Scales-42 (DASS-42) | Baseline, each treatment cycle |
| Quality of life, wellbeing | Women’s Quality of Life Questionnaire (WOMQOL) | Baseline, each treatment cycle |
| Sleep quality | Pittsburgh Sleep Quality Index (PSQI) | Baseline, each treatment cycle |
| Contextual stress | The Perceived Stress Scale (PSS) | Baseline, each treatment cycle |
| Sexual satisfaction | The New Sexual Satisfaction Scale-Short From (NSSS-S) | Baseline, each treatment cycle |
| Diet quality, alcohol and drug intake | Drug, Alcohol, and Food Questionnaire (DAF) | Baseline, each treatment cycle |
| Treatment side effects | Side Effects Questionnaire | Baseline, each treatment cycle |
| Treatment efficacy | Clinical Global Impression scale (CGI scale, Improvement scale) | End of treatment |
| Observer report | ||
| Change in premenstrual symptoms | Modified DRSP | Baseline, end of treatment |
* Clinician administered.